The European Association of Urology (EAU) published revised guidelines for second-line therapy in kidney cancer IKCC plays an important role on the Guidelines Committee to ensure the patient perspective is incorporated. The modified advisory is published in European Urology (2016) http://dx.doi.org/10.1016/j.eururo.2016.06.009
Powles T, et al. European Association of Urology Guidelines for Clear Cell Renal Cancers That Are Resistant to Vascular Endothelial Growth Factor Receptor–Targeted Therapy. Eur Urol (2016), http://dx.doi.org/10.1016/j.eururo.2016.06.009
See also New Options in Treatment of Advanced Renal Cancer by Axel Bex. Lancet Oncology, Volume 17, No. 7, p850–852, July 2016
